CIDR – IDENTIFICATION OF MODIFIERS OF 22Q11.2 DELETION SYNDROME BY WHOLE GENOME SEQUENCING IN BLOOD DNA (MORROW)
CIDR — 通过血液 DNA 中的全基因组测序鉴定 22Q11.2 缺失综合征的修饰因子(明天)
基本信息
- 批准号:10709067
- 负责人:
- 金额:$ 38.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-20 至 2023-12-31
- 项目状态:已结题
- 来源:
- 关键词:Alexander DiseaseBiologicalBloodBrain DiseasesChargeChromosomesCollaborationsCommunitiesCongenital clubfootConsultConsultationsCustomDNADataData AnalysesData SetDepositionDiGeorge SyndromeDiseaseDizygotic TwinsFailureFundingGenesGeneticGenetic DiseasesGenetic NondisjunctionGenetic ServicesGenomicsGenotypeGoalsGrantHealthHereditary DiseaseHeritabilityHumanHuman ResourcesIndividualInstitutesLaboratoriesLeadMeiotic RecombinationMethodologyMethylationModificationNational Human Genome Research InstituteNational Institute of Child Health and Human DevelopmentNaturePoliciesPremature BirthPreparationQuality ControlResearchResearch ContractsResearch DesignResearch PersonnelSNP genotypingSamplingServicesStatistical Data InterpretationStudy SectionSupport ContractsTimeUnited States National Institutes of HealthUniversitiesWashingtonautism spectrum disordercomputerized data processingcost effectivedata sharingdatabase of Genotypes and Phenotypesexome sequencinggender dysphoriagenetic architecturegenome sequencinggenome wide association studygenomic datainsightinterestmalenew technologyprogramsresearch facilitystatisticstechnology developmentwhole genome
项目摘要
Center for Inherited Disease Research (CIDR) Trans-NIH Collaboration
The Center for Inherited Disease Research [CIDR] represents an important collaboration between NICHD and NHGRI. Since 1996, Institutes of the NIH have participated in the CIDR contract with the Johns Hopkins University. This trans-NIH collaboration is supported by 10 ICs, with NHGRI serving as the lead IC. CIDR provides to NIH-supported grantees state-of-the-art genomics and statistical genetics services, including whole genome and whole exome sequencing, genome-wide association studies [GWAS] and methylation analysis. In addition to providing outstanding genomics services, CIDR also consults on study design and statistical analysis to NIH grantees. A prime reason for continuing this collaboration is that, as a result of the genomics data provided by CIDR, important new insights into genetic diseases/conditions can potentially move a field of research forward. In addition, the data produced by CIDR is required to be deposited in dbGaP so that the data will be available for further analysis by the scientific community at large.
All investigators requesting access through the NIH-funded CIDR Program must submit an electronic application to NIH. X01 applications are continuously accepted and are evaluated for scientific merit six times per year by the CIDR Access Committee. The CIDR Board of Governors, which is made up of representatives from the supporting ICs, serves as the second level of review and determines which projects are granted access to the CIDR facility.
NICHD has supported projects on dizygotic twinning, chromosome nondisjunction, male meiotic recombination, ADHA, pre-term birth, modifiers of Alexander Disease, clubfoot, autism, and brain diseases. There is currently a pending project on “The heritability and genetic architecture of gender dysphoria.” The diversity of topics shows the interest of investigators supported by a wide variety of NICHD’s scientific Branches.
The current CIDR contract supports whole genome sequencing in blood DNA for identification of modifiers of 22q11.2 deletion syndrome.
遗传疾病研究中心(CIDR)跨NIH合作
遗传性疾病研究中心(CIDR)代表了NICHD和NHGRI之间的重要合作。 自1996年以来,国家卫生研究院各研究所参加了与约翰霍普金斯大学签订的CIDR合同。这项跨NIH的合作由10个IC支持,NHGRI作为牵头IC。CIDR为NIH支持的受资助者提供最先进的基因组学和统计遗传学服务,包括全基因组和全外显子组测序,全基因组关联研究[GWAS]和甲基化分析。 除了提供出色的基因组学服务外,CIDR还为NIH资助者提供研究设计和统计分析方面的咨询。 继续这种合作的一个主要原因是,由于CIDR提供的基因组学数据,对遗传疾病/病症的重要新见解可能会推动研究领域的发展。 此外,CIDR产生的数据必须存入dbGaP,以便科学界进一步分析。
所有要求通过NIH资助的CIDR项目访问的研究者必须向NIH提交电子申请。 X 01申请持续接受,并由CIDR访问委员会每年评估六次科学价值。CIDR理事会由支持性IC的代表组成,是第二级审查机构,决定哪些项目可以使用CIDR设施。
NICHD支持的项目包括双卵双生、染色体不分离、男性减数分裂重组、ADHD、早产、亚历山大病修饰因子、马蹄内翻足、自闭症和脑部疾病。 目前有一个关于“性别焦虑症的遗传性和遗传结构”的项目正在进行中。 主题的多样性表明了研究人员的兴趣,这些研究人员得到了NICHD各种科学分支的支持。
目前的CIDR合同支持血液DNA的全基因组测序,以鉴定22q11.2缺失综合征的修饰物。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KIM DOHENY其他文献
KIM DOHENY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KIM DOHENY', 18)}}的其他基金
TO PROVIDE SEQUENCING SERVICES USING WHOLE GENOME SEQUENCING (GERMLINE FFPE) FOR NCI (KLEIN)
为 NCI (KLEIN) 提供使用全基因组测序(种系 FFPE)的测序服务
- 批准号:
10949135 - 财政年份:2023
- 资助金额:
$ 38.8万 - 项目类别:
PRETESTING: UPGRADE QC ARRAY TO GLOBAL SCREENING ARRAY (GSA) FOR NCI
预测试:将 QC Array 升级为 NCI 的全球筛查阵列 (GSA)
- 批准号:
10715793 - 财政年份:2022
- 资助金额:
$ 38.8万 - 项目类别:
ILLUMINA GLOBAL DIVERSITY ARRAY FOR NCI
NCI 的 ILLUMINA 全球多样性阵列
- 批准号:
10715776 - 财政年份:2022
- 资助金额:
$ 38.8万 - 项目类别:
GENOME-WIDE GENOTYPING OF EXISTING SAMPLES FROM ASIAN AMERICAN AND PACIFIC ISLANDER PARTICIPANTS IN THE CALIFORNIA TEACHERS STUDY COHORT
对加州教师研究队列中亚裔美国人和太平洋岛民参与者的现有样本进行全基因组基因分型
- 批准号:
10723615 - 财政年份:2022
- 资助金额:
$ 38.8万 - 项目类别:
COLLECTING WHOLE GENOME SEQUENCE DATA TO ENHANCE THE VALUE OF THE FIRST MULTI-CENTER STUDY OF COLORECTAL CANCER RISK FACTORS AND BIOLOGY IN NIGERIA
收集全基因组序列数据以提高尼日利亚首次结直肠癌风险因素和生物学多中心研究的价值
- 批准号:
10723617 - 财政年份:2022
- 资助金额:
$ 38.8万 - 项目类别:
WHOLE EXOME SEQUENCING, 90% AT 20X IN BLOOD FOR NCI
整个%20EXOME%20测序,%2090%%20AT%2020X%20IN%20BLOOD%20FOR%20NCI
- 批准号:
10715756 - 财政年份:2022
- 资助金额:
$ 38.8万 - 项目类别:
GENOTYPING SERVICES USING ILLUMINA GLOBAL DIVERSITY ARRAY (GDA) FOR NIDCR (FONTANA): Genetic markers of caries risk in diverse underserved children
使用 ILLUMINA GLOBAL D多样性阵列 (GDA) 为 NIDCR (FONTANA) 提供基因分型服务:不同服务不足儿童的龋齿风险遗传标记
- 批准号:
10710135 - 财政年份:2022
- 资助金额:
$ 38.8万 - 项目类别:
CIDR - GENOTYPING SERVICES USING WHOLE EXOME SEQUENCING FOR NCI
CIDR - 使用 NCI 全外显子组测序的基因分型服务
- 批准号:
10723616 - 财政年份:2022
- 资助金额:
$ 38.8万 - 项目类别:
WHOLE EXOME SEQUENCING, 90% AT 20X WITH 1-2% FAILURE RATE (BUCCAL/BLOOD) FOR NCI
整个%20EXOME%20测序,%2090%%20AT%2020X%20WITH%201-2%%20FAILURE%20RATE%20(颊/血)%20FOR%20NCI
- 批准号:
10723606 - 财政年份:2022
- 资助金额:
$ 38.8万 - 项目类别:
相似海外基金
investigation of novel biomarkers for depression by multi-omics analysis of the human biological hippocampus and blood samples
通过对人类生物海马体和血液样本进行多组学分析来研究抑郁症的新型生物标志物
- 批准号:
23K14804 - 财政年份:2023
- 资助金额:
$ 38.8万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Biological function of osteoporotic drugs on bone-specific blood vessels and perivascular cells
骨质疏松药物对骨特异性血管和血管周围细胞的生物学功能
- 批准号:
22K21006 - 财政年份:2022
- 资助金额:
$ 38.8万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Establishment of blood-based biomarkers to reflect age-related changes in biological membrane
建立基于血液的生物标志物以反映生物膜与年龄相关的变化
- 批准号:
22K19762 - 财政年份:2022
- 资助金额:
$ 38.8万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Biological effects of bisphosphonates on bone-specific blood vessels and perivascular cells
双膦酸盐对骨特异性血管和血管周围细胞的生物学效应
- 批准号:
22K17000 - 财政年份:2022
- 资助金额:
$ 38.8万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of blood-brain barrier-crossing antibodies utilizing the biological features of glucose transporters
利用葡萄糖转运蛋白的生物学特性开发血脑屏障跨越抗体
- 批准号:
21K18268 - 财政年份:2021
- 资助金额:
$ 38.8万 - 项目类别:
Grant-in-Aid for Challenging Research (Pioneering)
Biological action of PTH/PTHrP on bone-specific blood vessels and osteo-vascular interaction
PTH/PTHrP 对骨特异性血管和骨血管相互作用的生物学作用
- 批准号:
21H03103 - 财政年份:2021
- 资助金额:
$ 38.8万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular biological analysis on peripheral blood and pharyngeal mucosa of Kawasaki disease children
川崎病患儿外周血及咽黏膜的分子生物学分析
- 批准号:
16K10042 - 财政年份:2016
- 资助金额:
$ 38.8万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
HHSN2612012000151/HHSN2610006Base Contract Title: Preclinical Efficacy and Intermediate Biomarkers. Task Order Title: Modulation of miRNA Expression in Blood or Other Biological Fluids Compared wi
HHSN2612012000151/HHSN2610006基本合同标题:临床前功效和中间生物标志物。
- 批准号:
8947461 - 财政年份:2014
- 资助金额:
$ 38.8万 - 项目类别:
Development of Off-the-shelf Completely Biological Small-Diameter Blood Vessel wi
现成的全生物小直径血管的开发
- 批准号:
8497217 - 财政年份:2013
- 资助金额:
$ 38.8万 - 项目类别:
Establishment of the mesureing system for early diagnosis of Alzheimer's disease using blood biological markers.
建立利用血液生物标志物早期诊断阿尔茨海默病的测量系统。
- 批准号:
23790990 - 财政年份:2011
- 资助金额:
$ 38.8万 - 项目类别:
Grant-in-Aid for Young Scientists (B)